BioAge Labs
(NASDAQ) BIOA
BioAge Labs Financials at a Glance
Market Cap
$923.28M
Revenue (TTM)
$10.32M
Net Income (TTM)
-$89.93M
EPS (TTM)
-$2.41
P/E Ratio
-8.63
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$20.86
Volume
14,263
Open
$20.31
Price
$20.86
Volume
14,263
Open
$20.31
Previous Close
$20.86
Daily Range
$19.40 - $20.86
52-Week Range
$4.07 - $24.00
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$20.86
Volume
14,263
Open
$20.31
Previous Close
$20.86
Daily Range
$19.40 - $20.86
52-Week Range
$4.07 - $24.00
Estimated Earnings Date
Aug 6, 2026
BIOA News
BIOA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioAge Labs
Industry
Pharmaceuticals
Sector
Health CareEmployees
62
CEO
Kristen Fortney, PhD
Website
www.bioagelabs.comHeadquarters
Emeryville, CA 94804, US
BIOA Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-10%
Net Income Margin
-9%
Return on Equity
-26%
Return on Capital
-27%
Return on Assets
-23%
Earnings Yield
-11.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$923.28M
Shares Outstanding
44.45M
Volume
14.26K
Avg. Volume
459.69K
Financials (TTM)
Gross Profit
$9.00M
Operating Income
-$92.78M
EBITDA
-$79.70M
Operating Cash Flow
-$81.63M
Capital Expenditure
-$719.00K
Free Cash Flow
-$82.35M
Cash & ST Invst.
$281.10M
Total Debt
$5.56M
BioAge Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.77M
+91.0%
Gross Profit
$2.71M
+86.7%
Gross Margin
97.73%
N/A
Market Cap
$923.28M
N/A
Market Cap/Employee
$14.89M
N/A
Employees
62
N/A
Net Income
-$22.25M
-72.1%
EBITDA
-$22.15M
-75.3%
Quarterly Fundamentals
Total Cash
$383.19M
+19.6%
Total Debt
$4.03M
-60.9%
Accounts Receivable
$709.00K
+96.4%
Inventory
$0.00
N/A
Long Term Debt
$2.23M
-38.3%
Short Term Debt
$1.81M
-73.1%
Return on Assets
-22.62%
N/A
Return on Invested Capital
-26.64%
N/A
Free Cash Flow
-$24.07M
-35.3%
Operating Cash Flow
-$24.05M
-38.5%